Primary Record
910129-15-6
- In stock
- 1,657 g
- Purity
- 99.0 %
- CAS
- 910129-15-6
Compound Identifiers & Properties
- CAS
- 910129-15-6
- PubChem CID
- 57355711
- SMILES
- CCC(C)COC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O
- Canonical SMILES
- CCC(C)COC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F
Names & Synonyms
- 910129-15-6
- Capecitabine impurity D
- UNII-0JD5QG20W5
- 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine
- Capecitabine EP Impurity D
- RefChem:100789
- 0JD5QG20W5
- C15H22FN3O6
- Capecitabine impurity D CRS
- 2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate
- DTXSID20238368
- orb1907907
- CHEMBL2041683
- SCHEMBL12302028
- CTK5G8802
- DTXCID40160859
- WBAXSXXYPPILCT-DGHYOTGBSA-N
- 5'-Deoxy-5-fluoro-N4-(2-methyl-1-butyloxycarbonyl)cytidine
- ANW-66935
- AKOS016008179
- CS-T-51963
- ND16526
- AS-69552
- DB-338616
- RT-020603
- CS-0188772
- Cytidine, 5'-deoxy-5-fluoro-N-((2-methylbutoxy)carbonyl)-
- A900092
- F232925
- 2-methylbutyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
- Capecitabine EP Impurity D Mixture of Diastereomers
- 5'-Deoxy-5-fluoro-N-(2-methylbutoxy)carbonylcytidine
- Q27236862
- 5-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine
- (5'-DEOXY-5-FLUORO-N4-(2-METHYL-1-BUTYLOXYCARBONYL)CYTIDINE)
- 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]cytidine
- B0246-468068
- 2-methylbutyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate
- 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine (Capecitabine Impurity)
- 2-Methylbutyl(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate
- 5 inverted exclamation mark -Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]cytidine
- 5 inverted exclamation marka-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine
- 5''-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine(CapecitabineImpurity)
- (2RS)-2-Methylbutyl [1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
- (4E,6E)-8-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-3-ethylnona-4,6-dien-3-ol
- (6,6'-Dimethoxy-2,2'-biphenyldiyl)bis{bis[4-methoxy-3,5-bis(2-met hyl-2-propanyl)phenyl]phosphine}
- 2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihyd
- 2-METHYLBUTYL N-{1-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-METHYLOXOLAN-2-YL]-5-FLUORO-2-OXOPYRIMIDIN-4-YL}CARBAMATE
- 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine; 2-Methylbutyl N-[1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate; Capecitabine Imp. D (EP); (2RS)-2-Methylbutyl [1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate; Capecitabine Impurity D
- 910133-63-0
- 910134-30-4